 | • レポートコード：QYR2104Z1247 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、子宮頸がん検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（パパニコロウ塗抹検査、HPV DNA検査、VIA検査）、用途別市場規模（病院、研究所、診療所・クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・子宮頸がん検査の市場動向 ・企業の競争状況、市場シェア ・子宮頸がん検査の種類別市場規模（パパニコロウ塗抹検査、HPV DNA検査、VIA検査） ・子宮頸がん検査の用途別市場規模（病院、研究所、診療所・クリニック） ・子宮頸がん検査の北米市場規模2016-2027（アメリカ、カナダ） ・子宮頸がん検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮頸がん検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮頸がん検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮頸がん検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Hologic、Qiagen N.V.、Becton, Dickinson and Company、Hoffman-La Roche、Abbott Molecular、Arbor Vita Corporation、OncoHealth Corporation、Dell Guided Therapeutics, Inc.、CooperSurgical, Inc.） ・結論 |
Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.
Cervical cancer test market is dominated by United States in 2018. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.
Market Analysis and Insights: Global Cervical Cancer Test Market
The global Cervical Cancer Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cervical Cancer Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cervical Cancer Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cervical Cancer Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cervical Cancer Test market.
Global Cervical Cancer Test Scope and Market Size
Cervical Cancer Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cervical Cancer Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pap Smear Test
HPV DNA Test
VIA Test
Segment by Application
Hospitals
Laboratories
Physicians’ Offices & Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Hologic
Qiagen N.V.
Becton, Dickinson and Company
Hoffman-La Roche
Abbott Molecular
Arbor Vita Corporation
OncoHealth Corporation
Dell Guided Therapeutics, Inc.
CooperSurgical, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cervical Cancer Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pap Smear Test
1.2.3 HPV DNA Test
1.2.4 VIA Test
1.3 Market by Application
1.3.1 Global Cervical Cancer Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Physicians’ Offices & Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cervical Cancer Test Market Perspective (2016-2027)
2.2 Cervical Cancer Test Growth Trends by Regions
2.2.1 Cervical Cancer Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cervical Cancer Test Historic Market Share by Regions (2016-2021)
2.2.3 Cervical Cancer Test Forecasted Market Size by Regions (2022-2027)
2.3 Cervical Cancer Test Industry Dynamic
2.3.1 Cervical Cancer Test Market Trends
2.3.2 Cervical Cancer Test Market Drivers
2.3.3 Cervical Cancer Test Market Challenges
2.3.4 Cervical Cancer Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cervical Cancer Test Players by Revenue
3.1.1 Global Top Cervical Cancer Test Players by Revenue (2016-2021)
3.1.2 Global Cervical Cancer Test Revenue Market Share by Players (2016-2021)
3.2 Global Cervical Cancer Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cervical Cancer Test Revenue
3.4 Global Cervical Cancer Test Market Concentration Ratio
3.4.1 Global Cervical Cancer Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cervical Cancer Test Revenue in 2020
3.5 Cervical Cancer Test Key Players Head office and Area Served
3.6 Key Players Cervical Cancer Test Product Solution and Service
3.7 Date of Enter into Cervical Cancer Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cervical Cancer Test Breakdown Data by Type
4.1 Global Cervical Cancer Test Historic Market Size by Type (2016-2021)
4.2 Global Cervical Cancer Test Forecasted Market Size by Type (2022-2027)
5 Cervical Cancer Test Breakdown Data by Application
5.1 Global Cervical Cancer Test Historic Market Size by Application (2016-2021)
5.2 Global Cervical Cancer Test Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cervical Cancer Test Market Size (2016-2027)
6.2 North America Cervical Cancer Test Market Size by Type
6.2.1 North America Cervical Cancer Test Market Size by Type (2016-2021)
6.2.2 North America Cervical Cancer Test Market Size by Type (2022-2027)
6.2.3 North America Cervical Cancer Test Market Size by Type (2016-2027)
6.3 North America Cervical Cancer Test Market Size by Application
6.3.1 North America Cervical Cancer Test Market Size by Application (2016-2021)
6.3.2 North America Cervical Cancer Test Market Size by Application (2022-2027)
6.3.3 North America Cervical Cancer Test Market Size by Application (2016-2027)
6.4 North America Cervical Cancer Test Market Size by Country
6.4.1 North America Cervical Cancer Test Market Size by Country (2016-2021)
6.4.2 North America Cervical Cancer Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cervical Cancer Test Market Size (2016-2027)
7.2 Europe Cervical Cancer Test Market Size by Type
7.2.1 Europe Cervical Cancer Test Market Size by Type (2016-2021)
7.2.2 Europe Cervical Cancer Test Market Size by Type (2022-2027)
7.2.3 Europe Cervical Cancer Test Market Size by Type (2016-2027)
7.3 Europe Cervical Cancer Test Market Size by Application
7.3.1 Europe Cervical Cancer Test Market Size by Application (2016-2021)
7.3.2 Europe Cervical Cancer Test Market Size by Application (2022-2027)
7.3.3 Europe Cervical Cancer Test Market Size by Application (2016-2027)
7.4 Europe Cervical Cancer Test Market Size by Country
7.4.1 Europe Cervical Cancer Test Market Size by Country (2016-2021)
7.4.2 Europe Cervical Cancer Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cervical Cancer Test Market Size (2016-2027)
8.2 Asia-Pacific Cervical Cancer Test Market Size by Type
8.2.1 Asia-Pacific Cervical Cancer Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cervical Cancer Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cervical Cancer Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Cervical Cancer Test Market Size by Application
8.3.1 Asia-Pacific Cervical Cancer Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cervical Cancer Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cervical Cancer Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Cervical Cancer Test Market Size by Region
8.4.1 Asia-Pacific Cervical Cancer Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cervical Cancer Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cervical Cancer Test Market Size (2016-2027)
9.2 Latin America Cervical Cancer Test Market Size by Type
9.2.1 Latin America Cervical Cancer Test Market Size by Type (2016-2021)
9.2.2 Latin America Cervical Cancer Test Market Size by Type (2022-2027)
9.2.3 Latin America Cervical Cancer Test Market Size by Type (2016-2027)
9.3 Latin America Cervical Cancer Test Market Size by Application
9.3.1 Latin America Cervical Cancer Test Market Size by Application (2016-2021)
9.3.2 Latin America Cervical Cancer Test Market Size by Application (2022-2027)
9.3.3 Latin America Cervical Cancer Test Market Size by Application (2016-2027)
9.4 Latin America Cervical Cancer Test Market Size by Country
9.4.1 Latin America Cervical Cancer Test Market Size by Country (2016-2021)
9.4.2 Latin America Cervical Cancer Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cervical Cancer Test Market Size (2016-2027)
10.2 Middle East & Africa Cervical Cancer Test Market Size by Type
10.2.1 Middle East & Africa Cervical Cancer Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cervical Cancer Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cervical Cancer Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Cervical Cancer Test Market Size by Application
10.3.1 Middle East & Africa Cervical Cancer Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cervical Cancer Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cervical Cancer Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Cervical Cancer Test Market Size by Country
10.4.1 Middle East & Africa Cervical Cancer Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cervical Cancer Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Details
11.1.2 Hologic Business Overview
11.1.3 Hologic Cervical Cancer Test Introduction
11.1.4 Hologic Revenue in Cervical Cancer Test Business (2016-2021)
11.1.5 Hologic Recent Development
11.2 Qiagen N.V.
11.2.1 Qiagen N.V. Company Details
11.2.2 Qiagen N.V. Business Overview
11.2.3 Qiagen N.V. Cervical Cancer Test Introduction
11.2.4 Qiagen N.V. Revenue in Cervical Cancer Test Business (2016-2021)
11.2.5 Qiagen N.V. Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Cervical Cancer Test Introduction
11.3.4 Becton, Dickinson and Company Revenue in Cervical Cancer Test Business (2016-2021)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 Hoffman-La Roche
11.4.1 Hoffman-La Roche Company Details
11.4.2 Hoffman-La Roche Business Overview
11.4.3 Hoffman-La Roche Cervical Cancer Test Introduction
11.4.4 Hoffman-La Roche Revenue in Cervical Cancer Test Business (2016-2021)
11.4.5 Hoffman-La Roche Recent Development
11.5 Abbott Molecular
11.5.1 Abbott Molecular Company Details
11.5.2 Abbott Molecular Business Overview
11.5.3 Abbott Molecular Cervical Cancer Test Introduction
11.5.4 Abbott Molecular Revenue in Cervical Cancer Test Business (2016-2021)
11.5.5 Abbott Molecular Recent Development
11.6 Arbor Vita Corporation
11.6.1 Arbor Vita Corporation Company Details
11.6.2 Arbor Vita Corporation Business Overview
11.6.3 Arbor Vita Corporation Cervical Cancer Test Introduction
11.6.4 Arbor Vita Corporation Revenue in Cervical Cancer Test Business (2016-2021)
11.6.5 Arbor Vita Corporation Recent Development
11.7 OncoHealth Corporation
11.7.1 OncoHealth Corporation Company Details
11.7.2 OncoHealth Corporation Business Overview
11.7.3 OncoHealth Corporation Cervical Cancer Test Introduction
11.7.4 OncoHealth Corporation Revenue in Cervical Cancer Test Business (2016-2021)
11.7.5 OncoHealth Corporation Recent Development
11.8 Dell Guided Therapeutics, Inc.
11.8.1 Dell Guided Therapeutics, Inc. Company Details
11.8.2 Dell Guided Therapeutics, Inc. Business Overview
11.8.3 Dell Guided Therapeutics, Inc. Cervical Cancer Test Introduction
11.8.4 Dell Guided Therapeutics, Inc. Revenue in Cervical Cancer Test Business (2016-2021)
11.8.5 Dell Guided Therapeutics, Inc. Recent Development
11.9 CooperSurgical, Inc.
11.9.1 CooperSurgical, Inc. Company Details
11.9.2 CooperSurgical, Inc. Business Overview
11.9.3 CooperSurgical, Inc. Cervical Cancer Test Introduction
11.9.4 CooperSurgical, Inc. Revenue in Cervical Cancer Test Business (2016-2021)
11.9.5 CooperSurgical, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cervical Cancer Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pap Smear Test
Table 3. Key Players of HPV DNA Test
Table 4. Key Players of VIA Test
Table 5. Global Cervical Cancer Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cervical Cancer Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cervical Cancer Test Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cervical Cancer Test Market Share by Regions (2016-2021)
Table 9. Global Cervical Cancer Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cervical Cancer Test Market Share by Regions (2022-2027)
Table 11. Cervical Cancer Test Market Trends
Table 12. Cervical Cancer Test Market Drivers
Table 13. Cervical Cancer Test Market Challenges
Table 14. Cervical Cancer Test Market Restraints
Table 15. Global Cervical Cancer Test Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cervical Cancer Test Market Share by Players (2016-2021)
Table 17. Global Top Cervical Cancer Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer Test as of 2020)
Table 18. Ranking of Global Top Cervical Cancer Test Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cervical Cancer Test Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cervical Cancer Test Product Solution and Service
Table 22. Date of Enter into Cervical Cancer Test Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cervical Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cervical Cancer Test Revenue Market Share by Type (2016-2021)
Table 26. Global Cervical Cancer Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cervical Cancer Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cervical Cancer Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cervical Cancer Test Revenue Market Share by Application (2016-2021)
Table 30. Global Cervical Cancer Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cervical Cancer Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cervical Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cervical Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cervical Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cervical Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cervical Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cervical Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cervical Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cervical Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cervical Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cervical Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cervical Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cervical Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cervical Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cervical Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cervical Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cervical Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cervical Cancer Test Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cervical Cancer Test Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cervical Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cervical Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cervical Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cervical Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cervical Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cervical Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cervical Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cervical Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cervical Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cervical Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cervical Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cervical Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 62. Hologic Company Details
Table 63. Hologic Business Overview
Table 64. Hologic Cervical Cancer Test Product
Table 65. Hologic Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 66. Hologic Recent Development
Table 67. Qiagen N.V. Company Details
Table 68. Qiagen N.V. Business Overview
Table 69. Qiagen N.V. Cervical Cancer Test Product
Table 70. Qiagen N.V. Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 71. Qiagen N.V. Recent Development
Table 72. Becton, Dickinson and Company Company Details
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Cervical Cancer Test Product
Table 75. Becton, Dickinson and Company Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 76. Becton, Dickinson and Company Recent Development
Table 77. Hoffman-La Roche Company Details
Table 78. Hoffman-La Roche Business Overview
Table 79. Hoffman-La Roche Cervical Cancer Test Product
Table 80. Hoffman-La Roche Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 81. Hoffman-La Roche Recent Development
Table 82. Abbott Molecular Company Details
Table 83. Abbott Molecular Business Overview
Table 84. Abbott Molecular Cervical Cancer Test Product
Table 85. Abbott Molecular Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 86. Abbott Molecular Recent Development
Table 87. Arbor Vita Corporation Company Details
Table 88. Arbor Vita Corporation Business Overview
Table 89. Arbor Vita Corporation Cervical Cancer Test Product
Table 90. Arbor Vita Corporation Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 91. Arbor Vita Corporation Recent Development
Table 92. OncoHealth Corporation Company Details
Table 93. OncoHealth Corporation Business Overview
Table 94. OncoHealth Corporation Cervical Cancer Test Product
Table 95. OncoHealth Corporation Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 96. OncoHealth Corporation Recent Development
Table 97. Dell Guided Therapeutics, Inc. Company Details
Table 98. Dell Guided Therapeutics, Inc. Business Overview
Table 99. Dell Guided Therapeutics, Inc. Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 100. Dell Guided Therapeutics, Inc. Recent Development
Table 101. CooperSurgical, Inc. Company Details
Table 102. CooperSurgical, Inc. Business Overview
Table 103. CooperSurgical, Inc. Cervical Cancer Test Product
Table 104. CooperSurgical, Inc. Revenue in Cervical Cancer Test Business (2016-2021) & (US$ Million)
Table 105. CooperSurgical, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cervical Cancer Test Market Share by Type: 2020 VS 2027
Figure 2. Pap Smear Test Features
Figure 3. HPV DNA Test Features
Figure 4. VIA Test Features
Figure 5. Global Cervical Cancer Test Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Laboratories Case Studies
Figure 8. Physicians’ Offices & Clinics Case Studies
Figure 9. Cervical Cancer Test Report Years Considered
Figure 10. Global Cervical Cancer Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cervical Cancer Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cervical Cancer Test Market Share by Regions: 2020 VS 2027
Figure 13. Global Cervical Cancer Test Market Share by Regions (2022-2027)
Figure 14. Global Cervical Cancer Test Market Share by Players in 2020
Figure 15. Global Top Cervical Cancer Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer Test as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cervical Cancer Test Revenue in 2020
Figure 17. Global Cervical Cancer Test Revenue Market Share by Type (2016-2021)
Figure 18. Global Cervical Cancer Test Revenue Market Share by Type (2022-2027)
Figure 19. North America Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cervical Cancer Test Market Share by Type (2016-2027)
Figure 21. North America Cervical Cancer Test Market Share by Application (2016-2027)
Figure 22. North America Cervical Cancer Test Market Share by Country (2016-2027)
Figure 23. United States Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cervical Cancer Test Market Share by Type (2016-2027)
Figure 27. Europe Cervical Cancer Test Market Share by Application (2016-2027)
Figure 28. Europe Cervical Cancer Test Market Share by Country (2016-2027)
Figure 29. Germany Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cervical Cancer Test Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cervical Cancer Test Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cervical Cancer Test Market Share by Region (2016-2027)
Figure 39. China Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cervical Cancer Test Market Share by Type (2016-2027)
Figure 47. Latin America Cervical Cancer Test Market Share by Application (2016-2027)
Figure 48. Latin America Cervical Cancer Test Market Share by Country (2016-2027)
Figure 49. Mexico Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cervical Cancer Test Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cervical Cancer Test Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cervical Cancer Test Market Share by Country (2016-2027)
Figure 55. Turkey Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cervical Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Hologic Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 59. Qiagen N.V. Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 60. Becton, Dickinson and Company Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 61. Hoffman-La Roche Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 62. Abbott Molecular Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 63. Arbor Vita Corporation Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 64. OncoHealth Corporation Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 65. Dell Guided Therapeutics, Inc. Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 66. CooperSurgical, Inc. Revenue Growth Rate in Cervical Cancer Test Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の子宮頸がん検査市場 2021：企業別、地域別、種類・用途別 The Cervical Cancer Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界の子宮頸がんスクリーニング市場規模・現状・予測（2021年-2027年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…
- 世界のがん検査市場規模・現状・予測（2021年-2027年） Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-…
- 世界の子宮頸がん診断検査市場規模・現状・予測（2021年-2027年） Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Market Analysis and Insights: Global Cervical Cancer Diagnostic Tests Market The global Cervical Cancer Diagnostic Tests market size is…
- 世界の子宮頸がん治療法・診断市場規模・現状・予測（2021年-2027年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…